NasdaqCM - Delayed Quote USD

Estrella Immunopharma, Inc. (ESLA)

1.0300
-0.0800
(-7.21%)
At close: May 9 at 4:00:00 PM EDT
0.9647
-0.07
(-6.34%)
After hours: May 9 at 7:56:21 PM EDT

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue --
Earnings -1.05M

Q4'24

-1M
-800K
-600K
-400K
-200K
0
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

16.00
16.00 Average
1.0300 Current
16.00 High

Earnings Estimate

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 1111
Avg. Estimate -0.11-0.11-0.46-0.75
Low Estimate -0.11-0.11-0.46-0.75
High Estimate -0.11-0.11-0.46-0.75
Year Ago EPS -------0.46

Revenue Estimate

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 1111
Avg. Estimate --------
Low Estimate --------
High Estimate --------
Year Ago Sales --------
Sales Growth (year/est) ------0.00%

Earnings History

Currency in USD 9/30/2024 12/31/2024
EPS Est. -0.12-0.12
EPS Actual ---0.03
Difference --0.09
Surprise % --75.00%

EPS Trend

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Current Estimate -0.11-0.11-0.46-0.75
7 Days Ago 0000
30 Days Ago 0000
60 Days Ago 0000
90 Days Ago 0000

EPS Revisions

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
ESLA -------63.04%
S&P 500 13.06%3.09%8.02%13.74%

Upgrades & Downgrades

Maintains D. Boral Capital: Buy to Buy 2/21/2025
Initiated D. Boral Capital: Buy 2/18/2025

Related Tickers